Immunogenicity of a 2-Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial.

Rouphael NG, Branche AR, Diemert DJ, Falsey AR, Losada C, Baden LR, Frey SE, Whitaker JA, Little SJ, Kamidani S, Walter EB, Novak RM, Rupp R, Jackson LA, Babu TM, Kottkamp AC, Luetkemeyer AF, Immergluck LC, Presti RM, Bäcker M, Winokur PL, Mahgoub SM, Goepfert PA, Fusco DN, Atmar RL, Posavad CM, Netzl A, Smith DJ, Telu K, Mu J, McQuarrie LJ, Makowski M, Makhene MK, Crandon S, Montefiori DC, Roberts PC, Beigel JH, Coronavirus Variant Immunologic Landscape Trial (COVAIL) Study Team .

Open source

DOI: 10.1093/infdis/jiad323
Published: 2023-12-01
Container: J Infect Dis
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/infdis/jiad323,
  title = {Immunogenicity of a 2-Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial.},
  author = {Rouphael NG and  Branche AR and  Diemert DJ and  Falsey AR and  Losada C and  Baden LR and  Frey SE and  Whitaker JA and  Little SJ and  Kamidani S and  Walter EB and  Novak RM and  Rupp R and  Jackson LA and  Babu TM and  Kottkamp AC and  Luetkemeyer AF and  Immergluck LC and  Presti RM and  Bäcker M and  Winokur PL and  Mahgoub SM and  Goepfert PA and  Fusco DN and  Atmar RL and  Posavad CM and  Netzl A and  Smith DJ and  Telu K and  Mu J and  McQuarrie LJ and  Makowski M and  Makhene MK and  Crandon S and  Montefiori DC and  Roberts PC and  Beigel JH and  Coronavirus Variant Immunologic Landscape Trial (COVAIL) Study Team
.},
  year = {2023},
  journal = {J Infect Dis},
  doi = {10.1093/infdis/jiad323},
  url = {https://doi.org/10.1093/infdis/jiad323}
}

RIS

TY  - JOUR
TI  - Immunogenicity of a 2-Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial.
AU  - Rouphael NG
AU  -  Branche AR
AU  -  Diemert DJ
AU  -  Falsey AR
AU  -  Losada C
AU  -  Baden LR
AU  -  Frey SE
AU  -  Whitaker JA
AU  -  Little SJ
AU  -  Kamidani S
AU  -  Walter EB
AU  -  Novak RM
AU  -  Rupp R
AU  -  Jackson LA
AU  -  Babu TM
AU  -  Kottkamp AC
AU  -  Luetkemeyer AF
AU  -  Immergluck LC
AU  -  Presti RM
AU  -  Bäcker M
AU  -  Winokur PL
AU  -  Mahgoub SM
AU  -  Goepfert PA
AU  -  Fusco DN
AU  -  Atmar RL
AU  -  Posavad CM
AU  -  Netzl A
AU  -  Smith DJ
AU  -  Telu K
AU  -  Mu J
AU  -  McQuarrie LJ
AU  -  Makowski M
AU  -  Makhene MK
AU  -  Crandon S
AU  -  Montefiori DC
AU  -  Roberts PC
AU  -  Beigel JH
AU  -  Coronavirus Variant Immunologic Landscape Trial (COVAIL) Study Team
.
PY  - 2023
JO  - J Infect Dis
DO  - 10.1093/infdis/jiad323
UR  - https://doi.org/10.1093/infdis/jiad323
ER  -

APA

NG, R., AR, B., DJ, D., AR, F., C, L., LR, B., SE, F., JA, W., SJ, L., S, K., EB, W., RM, N., R, R., LA, J., TM, B., AC, K., AF, L., LC, I., RM, P., M, B., PL, W., SM, M., PA, G., DN, F., RL, A., CM, P., A, N., DJ, S., K, T., J, M., LJ, M., M, M., MK, M., S, C., DC, M., PC, R., JH, B., & ., C. V. I. L. T. (. S. T. (2023). Immunogenicity of a 2-Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial.. J Infect Dis. https://doi.org/10.1093/infdis/jiad323

Source records

europe-pmc · retrieved 2026-09-26T11:27:51.298Z